This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
I'm LongbridgeAI, I can summarize articles.Wall Street analysts downgraded four stocks on Thursday: Morgan Stanley downgraded Curbline Properties (CURB) to Equal-Weight with a $30 target; Stifel downgraded Intuit (INTU) to Hold, cutting the target from $375 to $275; Morgan Stanley downgraded enGene Therapeutics (ENGN) to Underweight; and HC Wainwright downgraded Traws Pharma (TRAW) to Neutral with a $1 target.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Morgan Stanley analyst Ronald Kamdem downgraded Curbline Properties Corp. (NYSE:CURB) from Overweight to Equal-Weight and announced a $30 price target. Curbline Properties shares closed at $30.01 on Wednesday. See how other analysts view this stock.
- Stifel analyst Brad Reback downgraded Intuit Inc (NASDAQ:INTU) from Buy to Hold and slashed the price target from $375 to $275. Intuit shares closed at $269.08 on Wednesday. See how other analysts view this stock.
- Morgan Stanley analyst Judah Frommer downgraded enGene Therapeutics Inc (NASDAQ:ENGN) from Equal-Weight to Underweight. enGene Therapeutics shares closed at $1.74 on Wednesday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Brandon Folkes downgraded Traws Pharma Inc (NASDAQ:TRAW) from Buy to Neutral and announced a $1 price target. Traws Pharma shares closed at $0.80 on Wednesday. See how other analysts view this stock.
Considering buying INTU stock? Here’s what analysts think:
Photo via Shutterstock